← All stocks

Generate Biomedicines, Inc.

GENB Scheduled selling only

CIK 0002100782 #2030 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$16.00K

$16.00K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$16.00K

$0.00 against sales at will

By person

7 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ARNOLD FRANCES

Director

—

$16.00K (1) scheduled

−$16.00K

463,944

0.3615%

$7.42M

−0.2%

Nally Michael

Chief Executive Officer

—

1,889,361

1.47%

$30.23M

+56.0%

AFEYAN NOUBAR

Director

—

1,562,500

1.22%

$25.00M

—

Bancel Stephane

Director

—

724,160

0.5642%

$11.59M

—

Mendillo Jane L

Director

—

1,500

0.0012%

$24.00K

—

Silvers Jason

President & CFO

—

1,000

0.0008%

$16.00K

—

Grous Beth

Chief People Officer

—

300

0.0002%

$4.80K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

ARNOLD FRANCES

1 Sep 2026

Director

Sold on a plan

1,000

$16.00

$16.00K

Show all 1 transactions →

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 2 Mar 2026